Genitourinary Cancer: Clinical Trials and Research
In addition to using the most advanced methods of diagnosis and treatment, the James Graham Brown Cancer Center participates and initiates a wide range of ongoing clinical trials and research, examining new approaches to treating genitourinary cancer. Physicians at the Brown Cancer Center are among the top researchers in the world and have developed and participated in many aspects of clinical research programs. These include new therapies that may not be available in other parts of the region. To learn more about available clinical trials, discuss options with your physician.
For more information regarding these clinical trials, please contact Lesia Ferguson at (502) 852-2891 or Liz Wilson at (502) 562-4657
Clinical Trials and Research
- 01.0486 - A Phase II Study of Cyclophosphamide, Etoposide, and Estramustine in Metastatic, Androgen-Independent Prostate Cancer (Stage III-IV) learn more
- 07.0297 - ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma learn more
- 07.0172 - A Randomized Trial of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitinib Therapy learn more
- 06.0472 - A Randomized, Double-blind, Multi-center Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastasis in Men with Hormone-Refractory Prostate Cancer learn more
|